Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.
Gagliato D, Reinert T, Rocha C, Tavares M, Pimentel S, Fuzita W, Araújo M, Matias D, Aleixo S, França B, Magaton É, Brito N, Cardoso AC, Castilho V.
Gagliato D, et al. Among authors: araujo m.
Oncol Ther. 2024 Jun 5. doi: 10.1007/s40487-024-00284-5. Online ahead of print.
Oncol Ther. 2024.
PMID: 38836997
Free article.